DUXAP8 and neoplasm: Mechanistically, the pseudogene DUXAP8 in non‐small cell lung cancer (NSCLC) represses tumor suppressors EGR1 and RHOB by recruiting histone demethylase LSD1 and histone methyltransferase EZH2, promoting cell proliferation, migration, and invasion [10].